Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04968990Phase 2Recruiting
Phase 2, open-label trial in Wilms' tumor (3 arms), sponsored by St. Jude Children's Research Hospital. Primary endpoint: Half circumference at 10 years. Started Aug 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04968990.